Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
2
×
clinical trials
deals
2
×
detroit blog main
detroit top stories
drug prices
2
×
eli lilly
generic drugs
glaxosmithkline
2
×
indiana blog main
indiana top stories
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
poseida therapeutics
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adalimumab (humira)
What
bio
2
×
roundup
appetite
approval
biogen’s
biopharmaceutical
black
bread
butter
buyout
cancer
cash
companies
convo
diabetes
diamond’s
drug
drugs
earlier
eli
failures
giant
grabbed
hasn’t
hold
lilly's
littered
lost
loxo
nash
new
news
notes
pharmaceutical
price
remains
road
strategy
talk
Language
Current search:
glaxosmithkline
×
bio
×
cancer
×
deals
×
" drug prices "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More